Claritin

Manufacturer
Bayer HealthCare LLC
Effective date
2025-12-05
Label type
HUMAN OTC DRUG LABEL
Version
12
Source
full-release
Hydrated at
2026-06-01 01:20:20

Label at a glance#

ProductClaritin Reditabs
Active ingredientLORATADINE
Label structure11 sections

Indications and uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat

Dosage and administration

place 1 tablet on tongue; tablet disintegrates, with or without water adults and children 6 years and over 1 tablet every 12 hours; not more than 2 tablets in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor

Storage and handling

safety sealed: do not use if the individual blister unit imprinted with Claritin® RediTabs® is open or torn store between 20° to 25°C (68° to 77°F) use tablet immediately after opening individual blister complies with USP Procedure 2 for Assay and Organic Impurities and Test 2 for Disintegration

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Loratadine 5 mg

Purpose

OTC - PURPOSE SECTION

Antihistamine

Uses

INDICATIONS & USAGE SECTION

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

  • runny nose
  • itchy, watery eyes
  • sneezing
  • itching of the nose or throat

Warnings

WARNINGS SECTION

OTC - DO NOT USE SECTION

Do not use if you have ever had an allergic reaction to this product or any of its ingredients.

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.

OTC - WHEN USING SECTION

When using this product do not take more than directed. Taking more than directed may cause drowsiness.

OTC - STOP USE SECTION

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • place 1 tablet on tongue; tablet disintegrates, with or without water
adults and children 6 years and over1 tablet every 12 hours; not more than 2 tablets in 24 hours
children under 6 years of ageask a doctor
consumers with liver or kidney diseaseask a doctor

Other information

STORAGE AND HANDLING SECTION

  • safety sealed: do not use if the individual blister unit imprinted with Claritin® RediTabs® is open or torn
  • store between 20° to 25°C (68° to 77°F)
  • use tablet immediately after opening individual blister
  • complies with USP Procedure 2 for Assay and Organic Impurities and Test 2 for Disintegration

Inactive ingredients

INACTIVE INGREDIENT SECTION

anhydrous citric acid, gelatin, mannitol, mint flavor

Questions or comments?

OTC - QUESTIONS SECTION

1-800-CLARITIN (1-800-252-7484) or www.claritin.com

SPL UNCLASSIFIED SECTION

Distributed by MSD Consumer Care, Inc.,
PO Box 377, Memphis, TN 38151 USA,
a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ USA.

PRINCIPAL DISPLAY PANEL - 10 Tablet Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 11523-7202-3

Non-Drowsy*

Claritin ®

RediTabs ®


loratadine 5 mg/antihistamine

Indoor & Outdoor

Allergies

*When taken as directed. See Drug Facts Panel.

12

Hour

Relief of:

  • Sneezing
  • Runny Nose
  • Itchy, Watery Eyes
  • Itchy Throat

    or Nose

No Water Needed

Melts in Your Mouth

10

ORALLY

DISINTEGRATING TABLETS
PDPPDPPDPPDPfront labelfront label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
904026Claritin RediTabs 5 MG 12HR Disintegrating Oral TabletPSN12
672558loratadine 5 MG Disintegrating Oral TabletPSN12
904026loratadine 5 MG Disintegrating Oral Tablet [Claritin]SBD12
672558loratadine 5 MG Disintegrating Oral TabletSCD12
904026Claritin 12HR RediTabs 5 MG Disintegrating Oral TabletSY12
904026Claritin 5 MG Disintegrating Oral TabletSY12

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
11523-7202-1ClaritinReditabs3 in 1 CARTONTABLET, ORALLY DISINTEGRATING312
11523-7202-1ClaritinReditabs10 in 1 BLISTER PACKTABLET, ORALLY DISINTEGRATING1012
11523-7202-3ClaritinReditabs10 in 1 BLISTER PACKTABLET, ORALLY DISINTEGRATING1012
11523-7202-3ClaritinReditabs1 in 1 CARTONTABLET, ORALLY DISINTEGRATING112

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
11523-7202-1EA - Each11523-72022d9569c3-1d2b-4a96-a48f-54e4ce505bd912012-07-24
11523-7202-3EA - Each11523-72028c62db1c-bc79-4bd8-aae5-46837fb33bf912012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
LoratadineACTIVE INGREDIENT7AJO3BO7QN4
LoratadineACTIVE MOIETY7AJO3BO7QN4
anhydrous citric acidINACTIVE INGREDIENTXF417D3PSL4
gelatinINACTIVE INGREDIENT2G86QN327L4
mannitolINACTIVE INGREDIENT3OWL53L36A4

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
11523-720211523-7202-1, 11523-7202-3

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 9 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
anhydrous citric acidANHYDROUS CITRIC ACIDXF417D3PSLTABLET, ORALLY DISINTEGRATING / ORAL117 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
gelatinGELATIN2G86QN327LTABLET, ORALLY DISINTEGRATING / ORAL120 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
anhydrous citric acidANHYDROUS CITRIC ACIDXF417D3PSLTABLET, ORALLY DISINTEGRATING / ORAL117 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
gelatinGELATIN2G86QN327LTABLET, ORALLY DISINTEGRATING / ORAL120 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
mannitolMANNITOL3OWL53L36ATABLET, ORALLY DISINTEGRATING / ORAL4364 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
gelatinGELATIN2G86QN327LTABLET, ORALLY DISINTEGRATING / ORAL120 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
mannitolMANNITOL3OWL53L36ATABLET, ORALLY DISINTEGRATING / ORAL4364 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
anhydrous citric acidANHYDROUS CITRIC ACIDXF417D3PSLTABLET, ORALLY DISINTEGRATING / ORAL117 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
mannitolMANNITOL3OWL53L36ATABLET, ORALLY DISINTEGRATING / ORAL4364 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021993-001CLARITIN REDITABSLORATADINE5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-12

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-12d4dbc9d85df4…
2026-10-15 13:18:302026-09N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-12c2088c7a36db…
2026-09-14 22:38:342026-08N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-1284e616aacf4f…
2026-08-18 06:07:402026-07N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-12caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-12011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-1231067a03dcf5…
2025-08-23 18:47 UTC2025-08N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-126a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-12fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-12b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-1203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-122680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-125bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-12d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-12d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-1279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-12301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-121e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-128072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-125c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-125d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-124b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-1274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-12bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-12782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-1287673890dc5c…
2021-03-12 10:30 UTC2021-03N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-125aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-128869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-12c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-123f01610625f2…
2019-09-15 20:21 UTC2019-09N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-12b00525d2431f…
2019-07-19 19:46 UTC2019-07N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-12ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-126a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-121c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-12ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-12a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-129b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-12a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-123f0d92c62455…
2023-05-13 08:27 UTC2023-05N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-12053a50430f4f…
2023-01-26 05:58 UTC2023-01N021993-001CLARITIN REDITABS5MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-12-123bdfa0b2c4d7…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Claritin ReditabsLORATADINEBayer HealthCare LLC7dc04b48-f053-4e4b-a493-9e8286d2a7912025-12-05WarningsExact identifier
ndc (package): 11523-7202-3
ndc (package): 11523-7202-1
ndc (product): 11523-7202
ndc11 (package): 11523720203
ndc11 (package): 11523720201
spl id: 45371bc6-b83d-a96d-e063-6294a90a7c40
spl set id: 7dc04b48-f053-4e4b-a493-9e8286d2a791

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.